Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).
暂无分享,去创建一个
H L Greene | D. Roden | D. Roden | A. Hallstrom | J. Verter | H. Greene | R. Capone | M. J. Gillespie | D. Richardson | M. Gillespie | D. Echt | J Verter | D S Echt | A H Barker | R J Capone | A P Hallstrom | D W Richardson | D M Roden | L M Friedman | M J Gillespie | D. Richardson | A. Hallstrom | A. Barker | L. Friedman | H. Greene | Lawrence M. Friedman | A. H. Barker
[1] R. Byington,et al. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. , 1984, Controlled clinical trials.
[2] M. Friedman,et al. Instantaneous and sudden deaths. Clinical and pathological differentiation in coronary artery disease. , 1973, JAMA.
[3] H T Davis,et al. Ventricular Ectopic Beats and Their Relation to Sudden and Nonsudden Cardiac Death After Myocardial Infarction , 1979, Circulation.
[4] C. Furberg. Effect of antiarrhythmic drugs on mortality after myocardial infarction. , 1983, The American journal of cardiology.
[5] C. J. Schwartz,et al. On the pathological diagnosis of acute ischaemic heart disease. , 1972, Atherosclerosis.
[6] J. Fleiss,et al. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. , 1988, The American journal of cardiology.
[7] G. Biörck,et al. “Sudden Death”‐What Are We Talking About? , 1972, Circulation.
[8] W. Kannel,et al. Premature mortality from coronary heart disease. The Framingham study. , 1971, JAMA.
[9] J. Goldberg,et al. Ventricular Premature Complexes and Sudden Death After Myocardial Infarction , 1981, Circulation.
[10] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[11] J. Fleiss,et al. Effect of digitalis treatment on survival after acute myocardial infarction. , 1985, The American journal of cardiology.
[12] A. Moss,et al. Digitalis‐associated Cardiac Mortality After Myocardial Infarction , 1981, Circulation.
[13] A. Jaffe,et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. , 1984, The American journal of cardiology.
[14] J. Bigger. Patients with malignant or potentially malignant ventricular arrhythmias: opportunities and limitations of drug therapy in prevention of sudden death. , 1985, Journal of the American College of Cardiology.
[15] L E Hinkle,et al. Clinical Classification of Cardiac Deaths , 1982, Circulation.
[16] Cardiac Arrhythmia Pilot Study Investigators. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. , 1988, The American journal of cardiology.
[17] Furberg Cd,et al. The beta‐blocker heart attack trial. , 1982 .
[18] T. Thom,et al. The recent decrease in CHD mortality. , 1975, Preventive medicine.
[19] J. Bigger. Antiarrhythmic treatment: an overview. , 1984, The American journal of cardiology.
[20] J. Goldberg,et al. Ventricular premature beats and mortality after myocardial infarction. , 1977, The New England journal of medicine.
[21] B. Lown,et al. Sudden cardiac death: the major challenge confronting contemporary cardiology. , 1979, The American journal of cardiology.
[22] J. Bigger,et al. Risk stratification after acute myocardial infarction. , 1978, The American journal of cardiology.
[23] J P Miller,et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.
[24] R. Hutchinson,et al. Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients. , 1984, Journal of the American College of Cardiology.
[25] S. Goldstein. The necessity of a uniform definition of sudden coronary death: witnessed death within 1 hour of the onset of acute symptoms. , 1982, American heart journal.